XML 17 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities    
Net loss $ (34,425) $ (8,928)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 7 218
Stock-based compensation 5,111 472
Interest expense 749 0
Income tax expense 41 56
Revaluation of contingent royalty obligation payable to Evolus Founders, a related party 11,400 0
Changes in assets and liabilities:    
Prepaid expenses and other current assets (739) (265)
Other assets 0 (1,383)
Accounts payable 378 (2,554)
Accrued expenses 3,825 167
Deferred rent (8) (5)
Net cash used in operating activities (13,661) (12,222)
Cash flows from investing activities    
Purchases of property and equipment (9) 0
Net cash used in investing activities (9) 0
Cash flows from financing activities    
Proceeds from initial public offering, net of underwriters fees 56,330 0
Proceeds from follow-on offering, net of underwriters fees 67,700 0
Related party borrowings 1,127 12,035
Payments on related party borrowings (5,000) 0
Payments for offering costs (1,060) 0
Minimum tax withholding paid on behalf of employees for share-based awards (239) 0
Net cash provided by financing activities 118,838 12,035
Change in cash and restricted cash 105,168 (187)
Cash and restricted cash, beginning 0 187
Cash, end of period 105,168 0
Noncash financing activities:    
Related party receivable 73,690 (72,014)
Related party borrowings (68,767) 0
Note obligation (140,688) 134,937
Contingent royalty obligation payable to Evolus Founders, a related party 39,700 0
Contingent promissory note payable to Evolus Founders, a related party 16,042 0
Capital contribution from parent, convertible note write-off 66,998 0
Capital distribution from parent 0 (62,922)
Capital contribution from parent, forgiveness of related party borrowings 13,188 0
Deferred offering costs (2,885) 0
Accounts payable, paid by parent $ (163) $ 0